Australian life science company EZZ is seeing strong growth in China with its nicotinamide mononucleotide (NMN) and bone growth supplements, supported by the use of social commerce platforms Kuaishou and Pinduoduo.
The introduction of a new ‘modern claims’ system in Malaysia has been welcomed by industry players as it could drive more clinical research, expand new product options for consumers, and open local and international market opportunities.
In our monthly nutra regulatory round-up, we look at the latest regulatory announcements happening across APAC, including South Korea's plans in implementing a customised health functional food system following the success of a four-year pilot program,...
Japanese companies are actively seeking overseas expansion through mergers and acquisitions, as seen in Rohto’s and Mitsui’s acquisition of Eu Yan Sang recently.
More than 110 health hazards involving 18 Foods with Function Claims (FFC) products were declared by FFC businesses over the past two weeks, Japan’s Consumer Affairs Agency (CAA) said.
This round-up looks at how international and regional health and nutrition companies have fared in their latest financial performance, featuring insights from Danone, Unilever, Otsuka, Kirin, and The a2 Milk Company.
The latest edition of Mondelez’s annual State of Snacking report has found that consumers in many markets across APAC are turning to snacks as an important means of fulfilling nutritional needs.
Several major infant formula brands, including a2 milk and Danone’s Aptamil, are successfully gaining market share despite a shrinking birth rate and tighter regulatory regime in China, their latest financial results have shown.
In this round-up, we look at some of the latest updates and insights from functional ingredients suppliers, including leadership changes at Sami-Sabinsa, PhytoGaia’s plans for a trial that examines multi-carotenoids’ benefits for weight management, Synbio...
Swiss start-up xLongevity is advocating the need to test the efficacy of nutrient supplementation and has started doing so in Asia, beginning with a nicotinamide adenine dinucleotide (NAD+) test currently offered in India.
Unilever says the launch of its hydration brand Liquid I.V. into China earlier this year came at “the right moment”, citing recent rapid growth in the country’s electrolyte beverage sector as a key factor.
Fruit intake in APAC remains well-below the recommended levels, despite around 90% of consumers being aware of its health benefits, says kiwi firm Zespri.
China’s infant formula giant Feihe says group profit was down 33.5 per cent in FY23, as the country struggles with raising its birth rate despite introducing a three-child policy three years ago.
Elivity, a new longevity supplement brand, has made its debut in Singapore and it aims to move Asia’s understanding of the category beyond the use of nicotinamide mononucleotide (NMN).
Today we are revealing the full speaker information, key topics, presentation titles and abstracts for the Growth Asia Summit 2024, with major brands including Nestle, Blackmores, PepsiCo, Haleon, Amway, Danone, Mondelez and lots more preparing to take...
Here is the round-up of the latest nutraceutical trends in Asia-Pacific, including exclusive analysis in Vietnam and India market trends, and how South Korea is seeing a fast growth for its functional probiotics market.
Bone and cognitive health needs are cited as the trending nutraceutical categories in Vietnam, but companies should keep in mind how the market is still heavily rooted in herbal formulations with a preference for basic dosage formats, despite its rapid...
New Zealand dairy giant Fonterra has predicted a volatile year ahead despite stellar performances from its China business and consumer product portfolios in the first half of the year, especially with milk prices expected to rise in the next few months.
From NMN supplements quality to new launches from Nestle China, Meiji, and FY23 results of Haleon and Bayer, here are the most-read stories on NutraIngredients-Asia in March 2024.
Japan’s Consumer Affairs Agency (CAA), which oversees the Foods with Function Claims (FFC) sector, is asking all businesses to declare any health hazards linked to their products in the wake of Kobayashi Pharmaceutical’s red yeast rice saga.
Red yeast rice extract production would need to fulfill three key elements of testing to ensure product safety, industry experts highlighted amid an ongoing crisis involving products made using Japan’s Kobayashi Pharmaceutical's red yeast rice raw...
Health & Happiness Group (H&H Group) says demand for its high-end adult nutrition brand Swisse Plus+, especially its nicotinamide adenine dinucleotide (NAD+) and liver health products, is key to the 37.4 per cent revenue jump for its adult nutrition...
See the latest developments from health and nutrition brands across Asia-Pacific, including Nin Jiom's debut in the healthy ageing space with the upcoming launch of a nicotinamide mononucleotide (NMN) supplement in Singapore, Nestle China's...
Japan’s Kobayashi Pharmaceutical is halting the production of all its red yeast rice raw material and supplements containing the raw material, following consumer complaints of kidney disease. The company is also recalling all of its products that contain...
Nin Jiom, the Hong Kong-based company known for its cough syrup product Pei Pa Koa, is venturing into the healthy ageing supplement space with a NMN (nicotinamide mononucleotide) product set to launch in Singapore.
The ASEAN Alliance of Health Supplement Associations (AAHSA) is planning to run a study that looks at the potential health care cost savings coming from the use of specific dietary supplements, such as omega-3, vitamin D, probiotics, and magnesium.
China’s dietary supplement giant BYHEALTH has reported strong revenue growth for its business last year, with operating revenue increasing by nearly 20 per cent led by demand for its protein and probiotics powder supplements.
New Zealand infant nutrition firm Haven is expanding into the plant-based space with the launch of an oat-milk based drink for toddlers aged one and above.
Nestle has launched a new milk powder containing mulberry leaf extract, tryptophan, vitamin B, and minerals in China to support sleep quality in adults.
South Korea’s functional proprietary probiotics market is growing at a faster rate than the generic gut health category, says the CEO of biotech firm AceBiome in our latest Nutrachampion podcast.
An abundance of innovation in the grey space between food and supplements has led to a ‘graveyard’ of innovative companies ill-prepared for the hurdles they must jump, a regulatory expert has warned.
In our monthly nutra regulatory round-up, we look at the latest regulatory announcements happening across APAC, including China’s food industry association planning to set industry standards for electrolyte drinks, Taiwan’s harsher penalties for firms...
The testing of 18 commercially available NMN (nicotinamide mononucleotide) supplements sold in Singapore found that most products did not meet label claims, and researchers have called for industry-wide effort in resolving the issue.
India’s nutraceutical sector is rapidly expanding with start-ups, local players, and international brands entering the space, but the market is far from overcrowded and there is still growth space, according to insiders.
Bayer’s nutritional business declined for the past year due to a weaker market environment in China and South East Asia, the company said in its FY23 financial results.
Here is the round-up of the latest nutraceutical trends in Asia-Pacific, including how the sales of dietary supplements in the re-opened TikTok Shop Indonesia have yet to recover to pre-closure levels, the never-before-seen demand for creatine in India,...
There is growing interest in Middle East’s nutraceutical sector, says Taiwan biotech firm TCI Co. Ltd, which is hoping to gain market share first through its collagen offerings.
China National Food Industry Association (CNFIA) is to set industry standards for electrolyte beverages, including its definition, technical and manufacturing, testing, labelling, and packaging requirements.
From India's nutraceutical regulations to consumer behaviour in Indonesia, and FY23 financial results from Kirin, Danone, and Otsuka Holdings, here are the most-read stories on NutraIngredients-Asia in February 2024.
Hemp Foods Australia has launched its first beauty-from-within supplement, a vegan collagen product for hair, skin, and nails, in what it says could help fill the gap for plant-based options.
Haleon says that its vitamins minerals supplements (VMS) portfolio has gained shares in an overall declining market in FY23, led by growth in its core VMS brands Centrum, Caltrate, and Emergen-C, with the CEO saying that the firm is “optimistic” on the...
See the latest developments from health and nutrition brands across Asia-Pacific, including Kao’s transfer of its functional beverage brand Healthya to Kirin, Bayer Consumer Health’s insights on market opportunities for prenatal to infant nutrition in...
There are just over two weeks left to grab a great deal on our early bird delegate rate for the Growth Asia Summit in Singapore, which features a raft of big name brands, innovative suppliers and pioneering researchers.
Japan may be an ageing society with a shrinking population, but with preconception care on the rise and a record number of babies born via in-vitro fertilisation (IVF) in recent years, companies such as Bayer Consumer Health are seeing growth opportunities...
Tummy Buddies, a start-up from Australia, has created a range of synbiotics flavoured water designed to address what it perceives as a lack of gut health products for toddlers.
Global food and beverage giant Nestle has its eye on expanding its premium and healthy ageing product portfolios as it seeks to return to ‘normalised’ growth.
Danone’s CEO says that its business in China has been “extremely strong” in FY23 with growth propelled by its specialised nutrition portfolio, which consists of infant and medical nutrition products.
Indian nutraceutical experts are not in favour of the government’s potential plan to give the country’s drug regulator control over the category, arguing that this would stifle industry development in the thriving sector.
The a2 milk Company says its infant formula sales in China had increased by 1.5 per cent in the first half of FY2024, although the market had shrunk almost 14 per cent in sales.